SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-23-009267
Filing Date
2023-05-11
Accepted
2023-05-11 08:01:01
Documents
67
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q mrns-20230331x10q.htm   iXBRL 10-Q 1309995
2 EX-31.1 mrns-20230331xex31d1.htm EX-31.1 13388
3 EX-31.2 mrns-20230331xex31d2.htm EX-31.2 13896
4 EX-32.1 mrns-20230331xex32d1.htm EX-32.1 7705
5 GRAPHIC mrns-20230331x10q004.jpg GRAPHIC 14134
6 GRAPHIC mrns-20230331x10q007.jpg GRAPHIC 70748
7 GRAPHIC mrns-20230331x10q008.jpg GRAPHIC 31918
  Complete submission text file 0001558370-23-009267.txt   6371547

Data Files

Seq Description Document Type Size
8 EX-101.SCH mrns-20230331.xsd EX-101.SCH 55628
9 EX-101.CAL mrns-20230331_cal.xml EX-101.CAL 52925
10 EX-101.DEF mrns-20230331_def.xml EX-101.DEF 181146
11 EX-101.LAB mrns-20230331_lab.xml EX-101.LAB 450049
12 EX-101.PRE mrns-20230331_pre.xml EX-101.PRE 306422
61 EXTRACTED XBRL INSTANCE DOCUMENT mrns-20230331x10q_htm.xml XML 955296
Mailing Address 5 RADNOR CORPORATE CENTER SUITE 500 100 MATSONFORD RD RADNOR PA 19087
Business Address 5 RADNOR CORPORATE CENTER SUITE 500 100 MATSONFORD RD RADNOR PA 19087 484-801-4670
MARINUS PHARMACEUTICALS, INC. (Filer) CIK: 0001267813 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36576 | Film No.: 23908925
SIC: 2834 Pharmaceutical Preparations